Savara Pharmaceuticals
SVRA
#6613
Rank
โ‚ฌ0.48 B
Marketcap
2,83ย โ‚ฌ
Share price
-6.58%
Change (1 day)
-16.17%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -โ‚ฌ69.84 Million

According to Savara Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚ฌ51.89 Million a decrease over its 2022 earnings that were of -โ‚ฌ36.19 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ69.84 Million34.6%
2023 -โ‚ฌ51.89 Million43.38%
2022 -โ‚ฌ36.19 Million-11.31%
2021 -โ‚ฌ40.8 Million-13.3%
2020 -โ‚ฌ47.06 Million-36.53%
2019 -โ‚ฌ74.15 Million13.76%
2018 -โ‚ฌ65.18 Million105.54%
2017 -โ‚ฌ31.72 Million34.11%
2016 -โ‚ฌ23.65 Million-37.43%
2015 -โ‚ฌ37.8 Million38.81%
2014 -โ‚ฌ27.23 Million33.62%
2013 -โ‚ฌ20.38 Million38.49%
2012 -โ‚ฌ14.72 Million24.59%
2011 -โ‚ฌ11.81 Million-36.5%
2010 -โ‚ฌ18.6 Million-3.14%
2009 -โ‚ฌ19.2 Million-23.28%
2008 -โ‚ฌ25.03 Million8.52%
2007 -โ‚ฌ23.06 Million-34.14%
2006 -โ‚ฌ35.02 Million184.43%
2005 -โ‚ฌ12.32 Million90.75%
2004 -โ‚ฌ6.46 Million190.35%
2003 -โ‚ฌ2.23 Million11.64%
2002 -โ‚ฌ2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ17.23 Million-75.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.24 Billion 224.94%๐Ÿ‡บ๐Ÿ‡ธ USA